Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The US Centers for Disease Control and Prevention's outside panel of vaccine experts this week discussed narrowing ...

The US Centers and Disease Control and Prevention is considering recommending annual Covid-19 shots to those who are older or ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Guidelines from the Advisory Committee on Immunization Practices help physicians decide what vaccines to recommend to patients and are also used for determining insurance coverage in the U.S. The ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

Tuesday was a relatively uneventful news day for Pfizer, especially following the pharmaceutical giant's disclosure on Monday ...

Less than a quarter of adults and around 13% of children have gotten a COVID-19 vaccination this past season, CDC data shows, ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021. "I wish I hadn't done it, ...